Sign In
Free Newsletter
Cellares raises $257M to scale automated cell therapy
The financing will help expand automated cell therapy manufacturing, funding global Smart Factories and boosting production for commercial use.
Cellares expands global reach with cell therapy tech
The company is growing quickly in New Jersey and internationally with Smart Factories, an FDA designation and key partnerships to advance scalable, cost-effective cell therapy manufacturing.
New Cellares facility a win for NJ’s innovation, life sciences sectors
“We are aligning ourselves with the state goals, with the goals of the township – to create new jobs, especially in the high-tech industry and in biopharmaceutical manufacturing,” said CEO and co-founder Fabian Gerlinghaus during the Jan. 29 ribbon cutting for the company's Smart Factory in Bridgewater.
